NCT06247852

Brief Summary

In Denmark, around 12,700 patients undergo Cesarean delivery (CD) annually, constituting approximately 20% of all childbirths in the country. Worldwide, the number is increasing each year, with more than 20 million CD performed annually. Postoperative pain after CD is typically moderate to severe in intensity and still constitutes a significant challenge, balancing effective pain relief and potential side effects. Correlations between moderate to severe acute pain and the development of persistent pain after CD is still unclear. Postsurgical persistent pain is a significant, often unrecognized clinical problem that causes distress and diminishes the quality of life for patients. Despite advances in understanding the factors contributing to persistent postsurgical pain and an increased focus on identifying patients at risk, the management and prevention of postsurgical persistent pain are still inadequate. It is important to gain further insights into this population, and we have a unique opportunity to do so by following the national cohort from the ongoing Danish multicenter cohort study on pain after cesarean section (ClinicalTrials.gov Identifier: NCT06012747) over an extended follow-up period. This involves continued prospective registration of Patient-Reported Outcome Measures (PROM) collected by SMS-based questionnaires in the months and years after the CD, thereby investigating the occurrence of both acute and persistent pain after CD. The outcomes are focused on pain levels, the impact of pain on physical function and neuropathic pain characteristics in the months and years following the CD. The study also aims to explore the relationship between persistent and acute pain.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
477

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2023

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

January 8, 2024

Completed
1 month until next milestone

First Posted

Study publicly available on registry

February 8, 2024

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 10, 2025

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2025

Completed
Last Updated

September 3, 2025

Status Verified

September 1, 2025

Enrollment Period

1.8 years

First QC Date

January 8, 2024

Last Update Submit

September 2, 2025

Conditions

Keywords

persistent painchronic painDanish cohortcesarean sectioncesarean deliveryacute on chronic painpost operative painSMS questionnaire

Outcome Measures

Primary Outcomes (1)

  • Persistent pain

    The percentage of patients reporting pain equivalent to an NRS score \> 3 after 6 months

    after 6 months

Secondary Outcomes (23)

  • Severe pain during the last 24 hours.

    Assessments are conducted at 5 weeks, 2, 3, 6, and 12 months, and after that every 6 months until 3 years after surgery.

  • Severe pain at rest during the last 24 hours.

    Assessments are conducted at 5 weeks, 2, 3, 6, and 12 months, and after that every 6 months until 3 years after surgery.

  • Use of analgesic medication in the past week due to pain (Paracetamol, Non-Steroidal Anti-Inflammatory Drug, opioid).

    Assessments are conducted at 5 weeks, 2, 3, 6, and 12 months, and after that every 6 months until 3 years after surgery.

  • Pain's affect on daily activities

    Assessments are conducted at 5 weeks, 2, 3, 6, and 12 months, and after that every 6 months until 3 years after surgery.

  • Pain's affect on engaging in strenuous physical activity.

    Assessments are conducted at 5 weeks, 2, 3, 6, and 12 months, and after that every 6 months until 3 years after surgery.

  • +18 more secondary outcomes

Other Outcomes (6)

  • Recall of acute pain at 12 and 24 hours after CD

    Asked 12 months after CD.

  • Percentage of patients experiencing pain with an NRS > 3

    1, 2, 3, and 12 months, as well as 1,5; 2; 2,5 and 3 years after cesarean delivery.

  • Association between severe acute pain (NRS > 6) during the first 24 hours and the occurrence of persistent pain at 6 and 12 months after CD.

    12 months

  • +3 more other outcomes

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsPatients having a cesarean section
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients, aged \> 18 years, who undergo planned cesarean delivery under spinal anesthesia.

You may qualify if:

  • Patients who, after participating in the Danish multicenter cohort study on pain after cesarean delivery (ClinicalTrials.gov Identifier: NCT06012747), consent to continue to receive questionnaires about persistent pain.
  • Planned cesarean delivery in spinal anesthesia
  • Patients who speak and read Danish
  • Patients with a smartphone that can receive an SMS with a link to a questionnaire that can be opened online.

You may not qualify if:

  • \<18 years of age

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Anesthesiology, Copenhagen University Hospital, North Zealand Hillerød

Hillerød, 3400, Denmark

Location

MeSH Terms

Conditions

Chronic PainPain, Postoperative

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsPostoperative ComplicationsPathologic Processes

Study Officials

  • Patricia Duch, MD

    University Hospital of Copenhagen, Hillerød, Denmark

    PRINCIPAL INVESTIGATOR
  • Helene Nedergaard, MD, Ph.D

    University Hospital of Southern Denmark, Kolding

    STUDY DIRECTOR
  • Christoffer Jørgensen, Dr. Med.

    University Hospital of Copenhagen, Hillerød, Denmark

    STUDY DIRECTOR
  • Kim Wildgaard, MD, Ph.d.

    University Hospital of Copenhagen, Herlev, Denmark

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Consultant, MD

Study Record Dates

First Submitted

January 8, 2024

First Posted

February 8, 2024

Study Start

September 1, 2023

Primary Completion

June 10, 2025

Study Completion

September 1, 2025

Last Updated

September 3, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Locations